Patient-derived xenograft mouse models of pseudomyxoma peritonei recapitulate the human inflammatory tumor microenvironment.

about

Current status and perspectives of patient-derived xenograft models in cancer research.Zebrafish Xenograft: An Evolutionary Experiment in Tumour Biology.

P2860

Q33667686-932E049C-1791-4E4A-8899-497BEEED1272 Q41673632-11E0754F-D47D-4C85-A0BD-0AA95D760806

P2860

Patient-derived xenograft mouse models of pseudomyxoma peritonei recapitulate the human inflammatory tumor microenvironment.

Item

http://www.wikidata.org/entity/Q36797297

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Patient-derived xenograft mous ...... matory tumor microenvironment.

@en

type

Item

label

Patient-derived xenograft mous ...... matory tumor microenvironment.

@en

prefLabel

Patient-derived xenograft mous ...... matory tumor microenvironment.

@en

P1476

Patient-derived xenograft mous ...... matory tumor microenvironment.

@en

P2093

Brian W Loggie

http://www.w3.org/2001/XMLSchema#string

Murali R Kuracha

http://www.w3.org/2001/XMLSchema#string

Peter Thomas

http://www.w3.org/2001/XMLSchema#string

Venkatesh Govindarajan

http://www.w3.org/2001/XMLSchema#string

P2860

A new standard of care for the management of peritoneal surface malignancy

Patient-derived tumor xenografts: transforming clinical samples into mouse models

Accessories to the crime: functions of cells recruited to the tumor microenvironment

Pseudomyxoma peritonei--two novel orthotopic mouse models portray the PMCA-I histopathologic subtype.

Activated Ras alters lens and corneal development through induction of distinct downstream targets.

Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei".

Human cancer growth and therapy in immunodeficient mouse models.

Pseudomyxoma peritonei is a disease of MUC2-expressing goblet cells.

Malignant ascites: past, present, and future.

P304

711-719

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CAM4.640

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

292952987

http://www.w3.org/2001/XMLSchema#string

P698

26833741

http://www.w3.org/2001/XMLSchema#string

P921

xenograft

P932

4831290

http://www.w3.org/2001/XMLSchema#string

Patient-derived xenograft mouse models of pseudomyxoma peritonei recapitulate the human inflammatory tumor microenvironment.

about

P2860

P2860

Patient-derived xenograft mouse models of pseudomyxoma peritonei recapitulate the human inflammatory tumor microenvironment.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932